BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 27012660)

  • 1. Distraction adds to the cognitive burden in multiple sclerosis.
    Patel VP; Zambrana A; Walker LA; Herrmann N; Feinstein A
    Mult Scler; 2017 Jan; 23(1):106-113. PubMed ID: 27012660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Processing speed and distractibility in multiple sclerosis: the role of sleep.
    Patel VP; Walker LA; Feinstein A
    Mult Scler Relat Disord; 2017 Jan; 11():40-42. PubMed ID: 28104254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.
    Akbar N; Honarmand K; Kou N; Feinstein A
    J Neurol; 2011 Mar; 258(3):373-9. PubMed ID: 20924594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
    Charvet LE; Beekman R; Amadiume N; Belman AL; Krupp LB
    J Neurol Sci; 2014 Jun; 341(1-2):79-84. PubMed ID: 24792098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental learning during rapid information processing on the symbol-digit modalities test.
    Denney DR; Hughes AJ; Elliott JK; Roth AK; Lynch SG
    Arch Clin Neuropsychol; 2015 Jun; 30(4):322-8. PubMed ID: 25857404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.
    Parmenter BA; Weinstock-Guttman B; Garg N; Munschauer F; Benedict RH
    Mult Scler; 2007 Jan; 13(1):52-7. PubMed ID: 17294611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deconstructing the symbol digit modalities test in multiple sclerosis: The role of memory.
    Patel VP; Walker LAS; Feinstein A
    Mult Scler Relat Disord; 2017 Oct; 17():184-189. PubMed ID: 29055455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.
    Van Schependom J; D'hooghe MB; Cleynhens K; D'hooge M; Haelewyck MC; De Keyser J; Nagels G
    Eur J Neurol; 2014 Sep; 21(9):1219-25, e71-2. PubMed ID: 24850580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
    Ruet A; Deloire MS; Charré-Morin J; Hamel D; Brochet B
    Mult Scler; 2013 Oct; 19(12):1665-72. PubMed ID: 23459569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Rapid Electronic Cognitive Assessment Measure for Multiple Sclerosis: Validation of Cognitive Reaction, an Electronic Version of the Symbol Digit Modalities Test.
    Middleton RM; Pearson OR; Ingram G; Craig EM; Rodgers WJ; Downing-Wood H; Hill J; Tuite-Dalton K; Roberts C; Watson L; Ford DV; Nicholas R;
    J Med Internet Res; 2020 Sep; 22(9):e18234. PubMed ID: 32965240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?
    Burggraaff J; Knol DL; Uitdehaag BMJ
    Eur Neurol; 2017; 77(5-6):246-252. PubMed ID: 28319952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distractibility in multiple sclerosis: The role of depression.
    Patel VP; Zambrana A; Walker LA; Herrmann N; Swartz RH; Feinstein A
    Mult Scler J Exp Transl Clin; 2016; 2():2055217316653150. PubMed ID: 28607730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
    Polychroniadou E; Bakirtzis C; Langdon D; Lagoudaki R; Kesidou E; Theotokis P; Tsalikakis D; Poulatsidou K; Kyriazis O; Boziki M; Papadopoulos G; Boura E; Sintila L; Hatzigeorgiou S; Ziamos C; Ioannidis P; Karacostas D; Grigoriadis N
    Mult Scler Relat Disord; 2016 Sep; 9():68-72. PubMed ID: 27645348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Neural Efficiency in Multiple Sclerosis Patients during the Symbol Digit Modalities Test: A Functional Magnetic Resonance Imaging Study.
    Fittipaldi-Márquez MS; Cruz-Gómez ÁJ; Sanchis-Segura C; Belenguer A; Ávila C; Forn C
    Neurodegener Dis; 2017; 17(4-5):199-207. PubMed ID: 28538226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.
    Benedict RH; Smerbeck A; Parikh R; Rodgers J; Cadavid D; Erlanger D
    Mult Scler; 2012 Sep; 18(9):1320-5. PubMed ID: 22277740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking the tester out of the SDMT: A proof of concept fully automated approach to assessing processing speed in people with MS.
    Patel VP; Shen L; Rose J; Feinstein A
    Mult Scler; 2019 Oct; 25(11):1506-1513. PubMed ID: 30079822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
    Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
    BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.